Segall Bryant & Hamill’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-477
| Closed | -$200K | – | 716 |
|
|
2022
Q4 | $200K | Sell |
477
-15
| -3% | -$6.29K | ﹤0.01% | 694 |
|
|
2022
Q3 | $204K | Sell |
492
-22
| -4% | -$9.12K | ﹤0.01% | 700 |
|
|
2022
Q2 | $253K | Sell |
514
-12
| -2% | -$5.91K | ﹤0.01% | 684 |
|
|
2022
Q1 | $295K | Sell |
526
-7,109
| -93% | -$3.99M | ﹤0.01% | 680 |
|
|
2021
Q4 | $5.77M | Sell |
7,635
-2,423
| -24% | -$1.83M | 0.05% | 308 |
|
|
2021
Q3 | $7.5M | Sell |
10,058
-2,920
| -22% | -$2.18M | 0.07% | 253 |
|
|
2021
Q2 | $8.36M | Sell |
12,978
-134
| -1% | -$86.3K | 0.08% | 239 |
|
|
2021
Q1 | $7.49M | Buy |
13,112
+1,645
| +14% | +$940K | 0.07% | 260 |
|
|
2020
Q4 | $6.68M | Sell |
11,467
-11,388
| -50% | -$6.63M | 0.07% | 244 |
|
|
2020
Q3 | $11.8M | Buy |
22,855
+2,606
| +13% | +$1.34M | 0.16% | 142 |
|
|
2020
Q2 | $9.14M | Sell |
20,249
-4,369
| -18% | -$1.97M | 0.15% | 143 |
|
|
2020
Q1 | $8.63M | Buy |
24,618
+744
| +3% | +$261K | 0.18% | 118 |
|
|
2019
Q4 | $8.83M | Sell |
23,874
-1,618
| -6% | -$599K | 0.14% | 153 |
|
|
2019
Q3 | $8.48M | Buy |
25,492
+91
| +0.4% | +$30.3K | 0.13% | 192 |
|
|
2019
Q2 | $7.94M | Buy |
25,401
+547
| +2% | +$171K | 0.12% | 208 |
|
|
2019
Q1 | $7.6M | Sell |
24,854
-358
| -1% | -$109K | 0.12% | 213 |
|
|
2018
Q4 | $5.86M | Buy |
25,212
+573
| +2% | +$133K | 0.1% | 241 |
|
|
2018
Q3 | $7.71M | Sell |
24,639
-1,132
| -4% | -$354K | 0.11% | 231 |
|
|
2018
Q2 | $7.44M | Sell |
25,771
-1,366
| -5% | -$394K | 0.11% | 232 |
|
|
2018
Q1 | $6.79M | Sell |
27,137
-1,787
| -6% | -$447K | 0.16% | 150 |
|
|
2017
Q4 | $6.9M | Sell |
28,924
-6,229
| -18% | -$1.49M | 0.15% | 155 |
|
|
2017
Q3 | $7.81M | Buy |
35,153
+3,790
| +12% | +$842K | 0.18% | 132 |
|
|
2017
Q2 | $7.1M | Sell |
31,363
-285
| -0.9% | -$64.5K | 0.17% | 136 |
|
|
2017
Q1 | $6.31M | Buy |
31,648
+3,000
| +10% | +$598K | 0.15% | 148 |
|
|
2016
Q4 | $5.22M | Buy |
28,648
+2,542
| +10% | +$463K | 0.13% | 166 |
|
|
2016
Q3 | $4.28M | Buy |
+26,106
| New | +$4.28M | 0.11% | 195 |
|